Skip to main content
Article
P1.07-019 Large Cell Neuroendocrine Carcinoma of the Lung: Prognostic Factors of Survival and Recurrence after R0 Surgical Resection: Topic: Local Treatment
Journal of Thoracic Oncology (2017)
  • Maria Cattoni, Thoracic Surgery, Swedish Cancer Institute, Seattle/WA/United States of America
  • Eric Vallieres, Thoracic Surgery, Swedish Cancer Institute, Seattle/WA/United States of America
  • Lisa Brown, University of California, Davis
  • Amir Sarkeshik, University of California, Davis
  • Stefano Margaritora, The Catholic University of America
  • Alessandra Siciliani, The Catholic University of America
  • Pier Luigi Filosso, Thoracic Surgery, San Giovanni Battista Hospital, Torino/Italy
  • Francesco Guerrera, Thoracic Surgery, San Giovanni Battista Hospital, Torino/Italy
  • Andrea Imperatori, University of Insubria
  • Nicola Rotolo, University of Insubria
  • Farhood Farjah, University of Washington Medical Center
  • Grace Wandell, University of Washington Medical Center
  • Kimberly Costas, Thoracic Surgery, Providence Regional Medical Center, Everett/WA/United States of America
  • Catherine Mann, Thoracic Surgery, Swedish Cancer Institute, Seattle/WA/United States of America
  • Michal Hubka, Virginia Mason Medical Center
  • Stephen Kaplan, Virginia Mason Medical Center
  • Alexander Farivar, Thoracic Surgery, Swedish Cancer Institute, Seattle/WA/United States of America
  • Ralph Aye, Thoracic Surgery, Swedish Cancer Institute, Seattle/WA/United States of America
  • Brian Louie, Thoracic Surgery, Swedish Cancer Institute, Seattle/WA/United States of America
Publication Date
January 1, 2017
DOI
10.1016/j.jtho.2016.11.931
Citation Information
Maria Cattoni, Eric Vallieres, Lisa Brown, Amir Sarkeshik, et al.. "P1.07-019 Large Cell Neuroendocrine Carcinoma of the Lung: Prognostic Factors of Survival and Recurrence after R0 Surgical Resection: Topic: Local Treatment" Journal of Thoracic Oncology Vol. 12 Iss. 1 (2017)
Available at: http://works.bepress.com/brian-louie/80/